Selective proteolytic cleavage of IL-2 receptor and IL-6 receptor ligand binding chains by neutrophil-derived serine proteases at foci of inflammation

Journal of Interferon and Cytokine Research

Volumn 19, Issue 11, 1999, Pages 1277-1287

  Bank, Ute ^a,d   Reinhold, Dirk ^a   Schneemilch, Christine ^b   Kunz, Dagmar ^c   Synowitz, Hans J ^d   Ansorge, Siegfried ^a  

^a Inst of Exp Internal Medicine   (Germany)

^b Clin Anesth Intensive Care Ther   (Germany)

^c Institute of Clinical Chemistry   (Germany)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN G; ELASTASE; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6 RECEPTOR; MYELOBLASTIN; SERINE PROTEINASE;

ARTICLE; BRAIN INJURY; CATALYSIS; CELL INFILTRATION; CLINICAL ARTICLE; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; HUMAN CELL; INFLAMMATION; LIGAND BINDING; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RECEPTOR SOLUBILIZATION;

ADOLESCENT; ADULT; AGED; BRAIN INJURIES; CATHEPSINS; FEMALE; HUMANS; HYDROLYSIS; INFLAMMATION; LIGANDS; MALE; MIDDLE AGED; MYELOBLASTIN; NEUTROPHILS; PANCREATIC ELASTASE; RECEPTORS, INTERLEUKIN-2; RECEPTORS, INTERLEUKIN-6; SERINE ENDOPEPTIDASES; SOLUBILITY;

EID: 0032733007     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099312957     Document Type: Article

References (43)

1. LLOYD, A.R., and OPPENHEIM, J.J. (1992). Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. Immunol. Today 13, 169-172.
2. CLARK, R.S., SCHIDING, J.K., KACZOROWSKI, S.L., MARION, D.W., and KOCHANEK, P.M. (1994). Neutrophil accumulation after traumatic brain injury in rats: comparison of weight drop and controlled cortical impact models. J. Neurotrauma 11, 499-506.
3. McD ANDERSON, R., and OPESKIN, K. (1998). Timing of early changes in brain trauma. Am. J. Forensic Med. Pathol. 19, 1-9.
4. GHIRNIKAR, R.S., LEE, Y.L., and ENG, L.F. (1998). Inflammation in traumatic brain injury: role of cytokines and chemokines. Neurochem. Res. 23, 329-340.
5. FEUERSTEIN, G.Z., LIU, T., and BARONE, F.C. (1994). Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha. Cerebrovasc. Brain Metab. Rev. 6, 341-360.
6. TAUPIN, V., TOULMOND, S., SERRANO, A., BENAVIDES, J., and ZAVALA, F. (1993). Increase in IL-6, IL-1 and TNF levels in the rat brain following tissue injury. J. Neuroimmunol. 42, 177-186.
7. BANK, U., REINHOLD, D., KUNZ, D., SCHULZ, H.-U., SCHNEEMILCH, C., BRANDT, W., and ANSORGE, S. (1995). Effects of interleukin-6 and transforming growth factor-β on neutrophil activation. Inflammation 19, 83-99.
8. KOSSMANN, T., HANS, V.H.J., IMHOF, H.-G., STOCKER, R., GROB, P., TRENTZ, O., and MORGANTI-KOSSMANN, M.C. (1995). Intrathekal and serum interleukin-6 and the acute-phase response in patients with severe head injuries. Shock 4, 311-317.
9. McCLAIN, C., COHEN, D., PHILLIPS, R., OTT, L., and YOUNG, A.B. (1991). Increased plasma and ventricular fluid interleukin-6 levels in patients with head injury. J. Lab. Clin. Med. 118, 226-231.
10. KOSSMANN, T., STAHEL, P., LENZLINGER, P.M., REDL, H., DUBS, R.W., TRENTZ, O., and MORGANTI-KOSSMANN, M.C. (1997). Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production. J. Cereb. Blood Flow Metab. 17, 280-289.
11. BAGGIOLINI, M., and CLARK-LEWIS, I. (1992). Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett. 307, 97-101.
12. BORISH, L., ROSENBAUM, R., ALBURY, L., and CLARK, S. (1989). Activation of neutrophils by recombinant interleukin-6. Cell. Immunol. 121, 280-289.
13. ROSEN, G.M., POU, S., RAMOS, C.L., COHEN, M.S., and BRITIGAN, B.E. (1995). Free radicals and phagocytic cells. FASEB J. 9, 200-209.
14. OLSSON, I., and VENGE, S. (1974). Cationic proteins of human granulocytes. II. Separation of the cationic proteins of granules of leukemic myeloid cells. Blood 44, 235-246.
15. BAUCH, R.J., and TRAVIS, J. (1976). Human leukocyte granule elastase: rapid isolation and characterization. Biochemistry 15, 836-841.
16. 1-proteinase inhibitor. Further evidence for methionine at the reactive center. J. Biol. Chem. 254, 4022-4026.
17. 1-antichymotrypsin by oxidatively activated human neutrophil metalloproteinases. J. Biol. Chem. 267, 5005-5012.
18. PADRINES, M., WOLF, M., WALZ, A., and BAGGIOLINI, M. (1994). Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3. FEBS Lett. 352, 231-235.
19. NORTIER, J., VANDENABEELE, P., NOEL, E., BOSSELOIR, Y., GOLDMAN, M., and DESCHODT-LANCKMAN, M. (1991). Enzymatic degradation of tumor necrosis factor by activated human neutrophils: role of elastase. Life Sci. 49, 1879-1886.
20. ROSE-JOHN, S., and HEINRICH, P.C. (1994). Soluble receptors for cytokines and growth factors: generation and biological function. Biochem. J. 300, 281-290.
21. MÜLLBERG, J., DURIE, F.H., OTTEN-EVANS, C., ALDERSON, M.R., ROSE-JOHN, S., COSMAN, D., BLACK. R.A., and MOHLER, K.M. (1995). A metalloproteinase inhibitor blocks the shedding of the IL-6 receptor and the TNF receptor. J. Immunol. 155, 5198-5205.
22. SCHULZ, O., SEWELL, H.F., and SHAKIB, F. (1998). Proteolytic cleavage of CD25, the α subunit of the human T cell interleukin 2 receptor, by Der p1, a major mite allergen with cysteine protease activity. J. Exp. Med. 187, 271-275.
23. PORTEU, F., BROCKHAUS, M., WALLACH, D., ENGELMANN, H., and NATHAN, C.F. (1991). Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor. J. Biol. Chem. 266, 18846-18853.
24. VOLLMER, P., WALEV, I., ROSE-JOHN, S., and BHAKDI, S. (1996). Novel pathogenic mechanism of microbial metalloproteinases: liberation membrane-anchored molecules in biological active form exemplified by studies with the human IL-6 receptor. Infect. Immun. 64, 3646-3651.
25. REINHOLD, D., BANK. U., BÜHLING, F., LENDECKEL, U., FAUST, J., NEUBERT, K., and ANSORGE, S. (1997). Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-β1 in PWM-stimulated PBMC and T cells. Immunology 91, 354-360.
26. BØYUM, A. (1968). Isolation of mononuclear cells and granulocytes by one step centrifugation and of granulocytes by combining centrifugation and sedimentation at 1g. Scand. J. Clin. Lab. Invest. 27(Suppl. 97), 77-89.
27. MOSMANN, T. (1983). Rapid colorimetric for cellular growth and survival: application to proliferation and cytotoxic assay. J. Immunol. Methods 65, 55-63.
28. BANGALORE, N., and TRAVIS, J. (1994). Comparison of the properties of membrane-bound versus soluble form of human leukocyte elastase and cathepsin G. Biol. Chem. Hoppe-Seyler 375, 659-666.
29. TADA, M., DISERENS, A.C., DESBAILLETS, I., and DE TRIBOLET, N. (1994). Analysis of cytokine receptor messenger RNA expression in human glioblastoma cells and normal astrocytes by reverse-transcription polymerase chain reaction. J. Neurosurg. 80, 1063-1073.
30. HANISCH, U.K., and QUIRION, R. (1996). Interleukin-2 as a neuroregulatory cytokine. Brain Res. Rev. 21, 246-248.
31. LEONARD, W.J., DEPPER, J.M., CRABTREE, G.R., RUDIKOFF, S., PUMPHREY, J., ROBB, R.J., KRONKE, M., SVETLIK, P.B., PFEFFER, N.J., and WALDMANN, T.A. (1984). Molecular cloning and expression of cDNA for the human interleukin-2 receptor. Nature 311, 626-631.
32. COSMAN, D., CERRETI, D.P., LARSEN, A., PARK, L., MARCH, C., DOWER, S., GILLIS, S., and URDAL, D. (1984). Cloning, sequence and expression of the human interleukin-2 receptor. Nature 312, 768-771.
33. YAMASAKI, K., TAGA, T., HIRATA, Y., YAMATA, H., KAWANISHI, Y., SEED, B., TANIGUCHI, T., HIRANO, T., and KISHIMOTO, T. (1988). Cloning and expression of the human interleukin-6 (BSF-2/IFN-β2) receptor. Science 241, 825-828.
34. MIEDEL, M.C., HULMES, J.D., and PAN, Y.C. (1989). Limited proteolysis of recombinant human soluble interleukin-2 receptor. Identification of an interleukin-2 binding core. J. Biol. Chem. 264, 21097-21105.
35. NEEPER, M.P., KUO, L.M., KIEFER, M.C., and ROBB, R.J. (1987). Structure-function relationships for the IL-2 receptor system. III. Tac protein missing amino acids 102 to 173 (exon 4) is unable to bind IL-2: detection of spliced protein after L cell transfection. J. Immunol. 138, 3532-3538.
36. BLOW, A.M. (1977). Action of human lysosomal elastase on the oxidized B chain of insulin. Biochem. J. 161, 13-16.
37. NAKAJIMA, K., POWER, J.C., ASHE, B.M., and ZIMMERMAN, M. (1979). Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. J. Biol. Chem. 254, 4027-4032.
38. OZBEK, S., GROTZINGER, J., KREBS, B., FISCHER, M., WOLLMER, A., JOSTOCK, T., MULLBERG, J., and ROSE-JOHN, S. (1998). The membrane proximal cytokine receptor domain of the human interleukin-6 receptor is sufficient for ligand binding but not for gp130 association. J. Biol. Chem. 273, 21374-21379.
39. DÖRING, G., FRANK, F., BOUDIER, C., HERBERT, S., FLEISCHER, B., and BELLON, G. (1995). Cleavage of the lymphocyte surface antigens CD2, CD4, and CD8 by polymorphonuclear leukocyte elastase and cathepsin G in patients with cystic fibrosis. J. Immunol. 154, 4842-4850.
40. REMOLD-O'DONNELL, E., and PARENT, D. (1995). Specific sensitivity of CD43 to neutrophil elastase. Blood 86, 2395-2402.
41. IGNOTZ, R.A., KELLY, B., DAVIS, R.J., and MASSAGUE, J. (1986). Biologically active precursor for transforming growth factor type alpha released by retroviral transformed cells. Proc. Natl. Acad. Sci. USA 83, 6307-6311.
42. HIBI, M., MURAKAMI, M., SAITO, M., HIRANO, T., TAGA, T., and KISHIMOTO, T. (1990). Molecular cloning and expression of an IL-6 signal transducer gp 130. Cell 63, 1149-1157.
43. MODUR, V., LI, Y., ZIMMERMANN, G.A., PRESCOTT, S.M., and McINTYRE, T.M. (1997). Retrograde inflammatory signalling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha. J. Clin. Invest. 100, 2752-2756.